Clinical Trial Update: Darusentan Effect on PET Uptake Heterogeneity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effect of darusentan on PET uptake heterogeneity in patients with coronary artery disease and endothelial dysfuncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Endothelial Dysfunction

Drugs mentioned

• Darusentan (darusentan)

Snippet

Sponsor: K.Lance Gould | Conditions: Coronary Artery Disease, Endothelial Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15